US EditionAfrica bears brunt of substandard cancer drugs with 20% fail rate - Juta MedicalBrief
Summary by Medical Brief
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Africa bears brunt of substandard cancer drugs with 20% fail rate - Juta MedicalBrief
In a landmark study by researchers at the University of Notre Dame, Indiana, USA, who analysed 189 samples of various vital cancer drugs, about one-fifth failed, leaving cancer patients around the world at risk of ineffective treatments and fatal side effects. The chemotherapy drugs in question form the backbone of treatment plans for numerous common cancers, including breast, ovarian and leukaemia, according to the global Bureau of Investigativ…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
